Categories
eleven News

Fidia Pharma USA Inc to exhibit at AAOS 2012 Annual Meeting

Fidia Pharma USA Inc will be exhibiting at the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco, February 7-11, 2012. Please come and see us at booth 4220 (Hall E).

We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee.

HYALGAN® is a treatment option for people who do not get adequate pain relief from simple painkillers (like Tylenol® or Advil®) or from exercise and physical therapy. HYALGAN® injections can be used in addition to prescription pain relievers (like Celebrex®).

Our Four Leading Principles:

Innovation

Quality

Globalization

Competitiveness